Chemical constituents and anticancer properties of bioactive compounds from Macrosphyra longistyla (DC.) Hiern.
Five compounds from Macrosphyra longistyla (Rubiaceae) exhibited moderate anticancer activity and inhibited the proliferation of triple-negative breast cancer cells, with 15-23% inhibition of cell viability compared to the standard drug paclitaxel (PTX; 94%).